Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Aptargroup (ATR)

Aptargroup (ATR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,419,311
  • Shares Outstanding, K 63,773
  • Annual Sales, $ 3,777 M
  • Annual Income, $ 392,790 K
  • EBIT $ 788 M
  • EBITDA $ 1,076 M
  • 60-Month Beta 0.49
  • Price/Sales 2.12
  • Price/Cash Flow 12.30
  • Price/Book 3.07

Options Overview Details

View History
  • Implied Volatility 32.11% (-3.80%)
  • Historical Volatility 27.91%
  • IV Percentile 88%
  • IV Rank 69.46%
  • IV High 37.97% on 04/10/25
  • IV Low 18.79% on 05/16/25
  • Expected Move (DTE 8) 5.36 (4.08%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 6
  • Volume Avg (30-Day) 15
  • Put/Call OI Ratio 0.66
  • Today's Open Interest 482
  • Open Int (30-Day) 494
  • Expected Range 126.04 to 136.76

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $1.15
  • Number of Estimates 4
  • High Estimate $1.17
  • Low Estimate $1.14
  • Prior Year $1.20
  • Growth Rate Est. (year over year) -4.17%

Price Performance

See More
Period Period Low Period High Performance
1-Month
120.31 +9.22%
on 03/20/26
134.13 -2.04%
on 03/10/26
-2.35 (-1.76%)
since 03/09/26
3-Month
120.31 +9.22%
on 03/20/26
146.91 -10.56%
on 02/24/26
+7.55 (+6.10%)
since 01/09/26
52-Week
103.23 +27.29%
on 10/31/25
164.28 -20.01%
on 07/24/25
-12.35 (-8.59%)
since 04/09/25

Most Recent Stories

More News
Aptar Digital Health Partners with Enable Injections for enFuse® Companion Digital Solution

Digital solution will be designed to help guide users through injection process

ATR : 131.40 (-0.47%)
Aptar’s Unidose Powder Nasal Delivery System Used in ENA Respiratory Phase II Clinical Study of Investigational INNA‑051 Nasal Spray

Use of Aptar Pharma’s UDS Powder system supports the development of a next‑generation, virus‑agnostic nasal spray being evaluated for its potential to help protect against symptomatic viral respiratory...

ATR : 131.40 (-0.47%)
Aptar Announces Gael Touya as its Next Chief Executive Officer; Stephan B. Tanda to Retire by the End of the Year

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that Gael Touya, a seasoned global executive with more...

ATR : 131.40 (-0.47%)
Aptar to Participate in Upcoming Investor Conferences

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today announced that it will present at two upcoming investor conferences:...

ATR : 131.40 (-0.47%)
AptarGroup: Q4 Earnings Snapshot

AptarGroup: Q4 Earnings Snapshot

ATR : 131.40 (-0.47%)
Aptar Reports Fourth Quarter and Annual 2025 Results

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today reported the following fourth quarter results for the period ended...

ATR : 131.40 (-0.47%)
Aptar Declares Quarterly Dividend and Announces 2026 Annual Meeting Details

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today announced that the Board declared a quarterly cash dividend of...

ATR : 131.40 (-0.47%)
Aptar Again Recognized with Prestigious ‘A’ Score on the CDP Climate Change Assessment

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery and consumer product dosing, dispensing and protection technologies, has been recognized for its leadership on climate change topics by the...

ATR : 131.40 (-0.47%)
Aptar Announces 2026 Quarterly Conference Call Dates

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today announced the dates and times of quarterly conference calls for...

ATR : 131.40 (-0.47%)
Aptar Digital Health and ŌURA Collaborate to Advance Migraine Insights by Connecting Migraine Buddy® with Oura Ring

The integration aims to empower millions of users with deeper insights into migraine triggers through biometric signals.

ATR : 131.40 (-0.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

AptarGroup, Inc. is a leading global supplier of a broad range of innovative dispensing systems for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food and beverage markets. AptarGroup is headquartered in Crystal Lake, Illinois, with manufacturing facilities...

See More

Key Turning Points

3rd Resistance Point 138.55
2nd Resistance Point 135.50
1st Resistance Point 133.45
Last Price 131.40
1st Support Level 128.34
2nd Support Level 125.29
3rd Support Level 123.24

See More

52-Week High 164.28
Fibonacci 61.8% 140.96
Fibonacci 50% 133.75
Last Price 131.40
Fibonacci 38.2% 126.55
52-Week Low 103.23

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.